MECP2 and Rett syndrome: MeCP2 Rett syndrome-associated mutations have been shown to affect the ability of MeCP2 to bind DNA and to compact polynucleosomal arrays in vitro (9, 11) and MeCP2 chromatin binding kinetics in vivo (12, –, 14).